Lincoln Pharma bags patent for anti-malarial drug
DSIJ Intelligence / 19 Dec 2017
Gujarat-based Lincoln Pharmaceuticals has received a patent for a anti-malarial drug in India. The anti-malarial drug (ARH 1) is a pioneer product of the company.
Gujarat-based Lincoln Pharmaceuticals has received a patent for a anti-malarial drug in India. The anti-malarial drug (ARH 1) is a pioneer product of the company.
The drug ARH 1 (Arteether) has been developed by the company utilizing Dose Optimization Technology. ARH 1 is a fast-acting blood schizonticidal agent which is easily administered through an injection and highly effective against the malaria parasite.
Lincoln Pharmaceuticals is an affordable therapeutic manufacturer of pharmaceutical products. The company offers tablets, capsules, injection, cream in tubes, dry power injection, and operates in cardiac, diabetic, anti-malarial, antibiotics segment.
The stock of Lincoln Pharmaceuticals closed at Rs. 222.25 per share, up by Rs. 6.80 or 3.16 per cent. Meanwhile, S&P BSE Sensex closed at 33,836.74, up 235.06 points or 0.70 per cent, Nifty50 closed at 10,463.20, up 74.45 points or 0.72 per cent.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.